Visit cardinalhealth.com for more information about Cardinal Health »

alt
Americas
Brazil flag
Brazil
English | Português
Canada flag
Canada
English
Puerto Rico flag
Puerto Rico
English
United States flag
United States
English
Europe, Middle East & Africa (EMEA)
Germany flag
Germany
Deutsch
Spain flag
Spain
Espanol
Europe, Middle East & Africa flag
Europe, Middle East & Africa
English
Asia-Pacific
Australia flag
Australia
English
China flag
China
中文
Japan flag
Japan
English | 日本語
Korea flag
Korea
English

News and Media

Latest News Release
Cardinal Health to acquire Specialty Networks and its PPS Analytics platform, a technology enabled multi-specialty group purchasing and practice enhancement organization
01/31/2024

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Cardinal Health Receives DEA Order toTemporarily Cease Distribution of Controlled Substances from Auburn, Wash. Facility
11/29/2007
Suspension affects only controlled substance shipments from the Washington facility
DUBLIN, Ohio, Nov. 29, 2007 — Cardinal Health today announced that the U.S. Drug Enforcement Administration (DEA) will temporarily suspend its license to distribute controlled substances from its Auburn, Wash. distribution center effective Dec. 3.
 
 
The company said the suspension affects only the Washington facility and only controlled substance shipments from that facility.  Steps are being taken to ensure continuity of service to its customers.
 
In an order received today, the DEA said Cardinal Health "failed to maintain effective controls against the diversion of a particular controlled substance," and cites the sale of hydrocodone to one pharmacy that allegedly dispensed excessive amounts of the drug based on illegitimate prescriptions from Internet pharmacy web sites.
 
Cardinal Health said the security of the pharmaceutical supply chain is among its highest priorities, and it will cooperate fully with the DEA to resolve the suspension.
 
About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is an $87 billion, global company serving the health care industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients.  With a focus on making supply chains more efficient, reducing hospital-acquired infections and breaking the cycle of harmful medication errors, Cardinal Health develops market leading technologies, including Alaris® IV pumps, Pyxis® automated dispensing systems, MedMined™ infection surveillance services and the CareFusion™ patient identification system.  The company also manufactures medical and surgical products and is one of the largest distributors of pharmaceuticals and medical supplies worldwide.  Ranked No. 19 on the Fortune 500 and No. 1 in its sector on Fortune's ranking of Most Admired firms, Cardinal Health employs more than 40,000 people on five continents.  More information about the company may be found at www.cardinalhealth.com.

More Company News
Cardinal Health Reaffirms Fiscal 2024 non-GAAP EPS Guidance and Long-term Targets Amidst Nonrenewal of OptumRx Customer Contracts
04/22/2024

Cardinal Health (NYSE: CAH) announced today that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024, will not be renewed. The company reaffirmed its...

Cardinal Health announces location of pharmaceutical distribution center for over-the-counter products
04/02/2024

The Consumer Health Logistics Center will be located in Central Ohio and serve as a centralized hub for distribution of consumer health products COLUMBUS, Ohio, April 2, 2024 /PRNewswire/ --...

Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2024 on May 2
03/26/2024

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2024 on May 2, prior to the opening of trading on the New York Stock Exchange. The company will...

Cardinal Health announces approved science-based climate targets; expands focus across the supply chain
03/15/2024

Cardinal Health (NYSE: CAH) today announced that the company has received approval by the Science Based Targets initiative (SBTi) for its near-term science-based greenhouse gas (GHG) emissions...

View all company news »